APVO Aptevo Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 14, 2026
$1,76
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,00minimo 52 sett.
$18,72massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$2M
P/E
-0.0
EPS
$-87.27
i tuoi badge
Intervallo 52 sett.
$1–$19
Rating Analisti
BUY
Prezzo Obiettivo
$26
P/E
-0.0
ROE
-217.2%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
APVO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.76
Capitalizzazione di Mercato (MRQ)
$2M
P/E
-0.0
EPS
$-87.27
ROE
-217.2%
Intervallo 52 sett.
$1–$19
APVO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 30 Dicembre 2025 | 1-for-18 | Inverso |
| 27 Maggio 2025 | 1-for-20 | Inverso |
| 04 Dicembre 2024 | 1-for-37 | Inverso |
| 06 Marzo 2024 | 1-for-44 | Inverso |
| 27 Marzo 2020 | 1-for-14 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2016-12-31 → 2022-12-31
EPS$-87.272021-12-31 → 2025-12-31
Flusso di cassa libero·2016-12-31 → 2022-12-31
Margine netto·2016-12-31 → 2022-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | APVO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.0media 5 anni ≈1179.2 | ≈1179.2 | · | · | |
| P/S | 0.1media 5 anni ≈53750.5 | ≈53750.5 | 13.0 | Sottovalutato | |
| P/B (MRQ) | 0.4media 5 anni ≈213755.0 | ≈213755.0 | 0.7 | Più costoso | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -0.1media 5 anni ≈-18183.8 | ≈-18183.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.1media 5 anni ≈213755.0 | ≈213755.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | APVO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -121.4%media 5 anni ≈-66.7% | ≈-66.7% | -125.6% | Di prim'ordine | |
| ROE | -217.2%media 5 anni ≈-298.8% | ≈-298.8% | -217.2% | In linea | |
| ROIC | -151.4% | · | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | APVO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 2.1media 5 anni ≈2.6 | ≈2.6 | 2.2 | Bassa liquidità | |
| Quick Ratio | 3.6media 5 anni ≈2.2 | ≈2.2 | 1.9 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-105.8%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 14, 2026 | $-5.31 | $-6.14 | 13.5% |
| 31 Marzo 2026 | Mag 12, 2026 | $-6.41 | $-5.71 | -12.2% |
| 31 Dicembre 2025 | $-0.01 | $-8.25 | 99.9% | |
| 30 Settembre 2025 | $-33.48 | $-38.37 | 12.7% | |
| 30 Giugno 2025 | $-151.20 | $-1527.55 | 90.1% | |
| 31 Marzo 2025 | $-1580.40 | $-1545.91 | -2.2% | |
| 31 Dicembre 2024 | $-29653.20 | $-2845.80 | -942.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $3M | $12M | $4M | $32M | $23M | $15M | $10M | $34M | |
| Cost of Revenue | · | · | · | · | · | · | $20M | $11M | $5M | $12M | $17M | |
| R&D Expense | $15M | $14M | $17M | $18M | $19M | $18M | $25M | $35M | $29M | $29M | $35M | |
| SG&A Expense | $12M | $10M | $12M | $14M | $15M | $14M | $16M | $28M | $35M | $36M | $43M | |
| Operating Income | $-26M | $-25M | $-29M | $-29M | $-21M | $-27M | $-41M | $-52M | $-54M | $-139M | $-61M | |
| Other Non-op | $345.0K | $472.0K | $578.0K | $-4M | $-8M | $-1M | $-2M | $-2M | $-2M | $-810.0K | $-237.0K | |
| Pretax Income | $-26M | $-24M | $-19M | $7M | $-29M | $-31M | $-43M | $-54M | $-56M | $-140M | $-61M | |
| Income Tax | $0 | · | · | · | · | · | · | · | $-23M | $-20M | $-2M | |
| Net Income | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | $-59M | |
| EPS (Basic) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| EPS (Diluted) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| Shares (Basic) | 315,535 | 767 | 7,515 | 5,100,310 | 4,687,952 | · | · | · | · | · | · | |
| Shares (Diluted) | 315,535 | 767 | 7,515 | 5,102,914 | 4,687,952 | · | · | · | · | · | · | |
| EBITDA | $-26M | $-24M | $-28M | $-28M | $-20M | · | $-40M | $-49M | · | $-124M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $9M | $17M | $23M | $45M | $40M | $12M | $31M | $7M | $10M | $5M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $74M | $45M | · | |
| Receivables | · | · | · | · | · | · | $7M | $5M | $2M | $307.0K | $6M | |
| Inventory | · | · | · | · | · | · | $6M | $2M | $1M | $461.0K | $20M | |
| Prepaid Expense | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $7M | $4M | $6M | $2M | |
| Other Current Assets | $853.0K | $1M | $689.0K | $744.0K | $780.0K | $133.0K | $160.0K | $4M | $7M | $2M | · | |
| Current Assets | $23M | $11M | $19M | $27M | $53M | $47M | $30M | $49M | $95M | $71M | $35M | |
| PP&E (Net) | $303.0K | $543.0K | $895.0K | $1M | $2M | $3M | $4M | $5M | $6M | $6M | $4M | |
| PP&E (Gross) | $14M | $14M | $14M | $14M | $15M | $14M | $14M | $14M | $13M | $13M | $10M | |
| Accum. Depreciation | $14M | $14M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $29M | |
| Intangibles | · | · | · | · | · | · | $4M | $5M | $6M | $7M | · | |
| Other Non-current Assets | · | · | · | · | $68.0K | $746.0K | $757.0K | $905.0K | · | · | · | |
| Total Assets | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Accounts Payable | $877.0K | $1M | · | · | · | · | $6M | $12M | · | · | $10M | |
| Current Liabilities | $6M | $6M | $7M | $9M | $35M | $15M | $38M | $18M | $19M | $20M | $20M | |
| Capital Leases | $4M | $5M | $5M | $6M | $1M | $2M | $3M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $16M | |
| Other Non-current Liabilities | · | $0 | · | · | · | · | · | $200.0K | $734.0K | $469.0K | $71.0K | |
| Total Liabilities | $10M | $11M | $13M | $16M | $55M | $37M | $42M | $37M | $35M | $41M | $39M | |
| Long-term Debt | · | · | $0 | $4M | $16M | $28M | · | · | $19M | · | · | |
| Total Debt | · | · | · | $3M | $12M | · | $20M | $19M | · | $18M | · | |
| Common Stock | $114.0K | $84.0K | $61.0K | $48.0K | $47.0K | $46.0K | $45.0K | $23.0K | $22.0K | $20.0K | · | |
| Retained Earnings | $-275M | $-248M | $-223M | $-206M | $-214M | $-186M | $-168M | $-127M | $-74M | $-81M | $-232M | |
| AOCI | · | · | · | · | · | · | · | · | $-105.0K | $-33.0K | · | |
| Stockholders' Equity | $17M | $5M | $12M | $18M | $1M | $17M | $12M | $30M | $82M | $51M | $89M | |
| Liabilities + Equity | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Shares Outstanding | 997,830 | 4,051 | 11,958 | 6,466,294 | 4,898,143 | 4,410,909 | 3,234,231 | 22,808,416 | 21,605,716 | 20,271,737 | 0 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $240.0K | $352.0K | $567.0K | $901.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | |
| Stock-based Comp | $96.0K | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $5M | $4M | $1M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $-11M | $-15M | $-1M | |
| Amort. of Intangibles | · | · | · | · | · | · | $800.0K | $800.0K | $800.0K | $800.0K | $3M | |
| Other Non-cash | $39.0K | $-1M | $3M | $-32M | $4M | · | $-6M | $-2M | · | $84M | · | |
| Operating Cash Flow | $-26M | $-24M | $-12M | $-21M | $-22M | $-29M | $-42M | $-51M | $-42M | $-37M | $-49M | |
| CapEx | · | · | · | $29.0K | $713.0K | $88.0K | $153.0K | $976.0K | $1M | $3M | $2M | |
| Investing Cash Flow | $0 | $0 | $0 | $-29.0K | $-713.0K | $28M | $4M | $73M | $29M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $20M | · | |
| Net Debt Issued | · | $0 | $-3M | $-12M | $-11M | · | · | · | · | $20M | · | |
| Stock Issued | $38M | $10M | $6M | $7M | $10M | · | · | $623.0K | $442.0K | · | · | |
| Net Stock Activity | $38M | $10M | · | $7M | $10M | · | · | $623.0K | · | · | · | |
| Financing Cash Flow | $38M | $16M | $6M | $-3M | $26M | $24M | $20M | $-787.0K | $20M | · | · | |
| Net Change in Cash | $13M | $-8M | $-6M | $-24M | $4M | $23M | $-18M | $21M | $7M | $5M | $1M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-21M | $-22M | · | $-43M | $-52M | · | $-39M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -919.8% | -174.1% | · | -131.4% | -224.0% | · | -348.4% | · | |
| Net Margin | · | · | · | 257.8% | -231.5% | · | -124.8% | -232.8% | · | -308.5% | · | |
| Pretax Margin | · | · | · | 225.2% | -239.2% | · | -137.8% | -232.8% | · | -350.6% | · | |
| EBITDA Margin | · | · | · | -890.8% | -164.8% | · | -124.5% | -213.6% | · | -339.2% | · | |
| ROA | -121.4% | -119.4% | -59.0% | 17.7% | -51.7% | · | -66.9% | -58.2% | · | -99.8% | · | |
| ROE | -217.2% | -526.0% | -129.3% | 47.6% | -668.9% | · | -256.1% | -144.3% | · | -152.2% | · | |
| ROIC | -151.4% | · | · | · | · | · | · | · | · | -162.0% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 | · | 0.8 | 2.8 | · | 3.7 | · | |
| Quick Ratio | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 | · | 0.5 | 2.0 | · | 3.0 | · | |
| Debt / Equity | · | · | · | 0.2 | 9.6 | · | 1.7 | 0.6 | · | 0.4 | · | |
| LT Debt / Equity | · | · | · | 0.1 | · | · | · | 0.6 | · | 0.4 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.1 | 0.2 | · | 0.5 | 0.2 | · | 0.3 | · | |
| Inventory Turnover | · | · | · | · | · | · | 5.0 | · | · | 1.8 | · | |
| Receivables Turnover | · | · | · | · | · | · | 5.3 | 6.3 | · | 6.8 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.42 | $3.26 | $0.63 | $2.78 | $0.25 | · | $0.26 | $1.33 | · | $2.49 | · | |
| Revenue / Share | · | · | · | $0.61 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-81.11 | $-86.13 | $-0.96 | $-4.12 | · | · | · | · | · | · | · | |
| Cash / Share | $21.67 | $5.97 | $0.87 | $3.50 | $9.20 | · | $0.27 | $1.34 | · | $0.48 | · | |
| EPS (TTM) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -74.7% | 185.3% | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | $12M | $3M | $12M | $4M | $32M | $23M | $15M | $10M | · | |
| Net Income TTM | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | · | |
| Market Cap | $9M | $126M | $114.73B | $488.46B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| Enterprise Value | · | · | · | $488.44B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| P/E | -0.1 | -0.0 | -2.5 | 48114.1 | -42215.4 | · | · | · | · | · | · | |
| P/S | 0.8 | 10.7 | 9772.0 | 156858.9 | 102109.9 | · | 416952.2 | 572427.1 | · | 2258110.4 | · | |
| P/B | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | · | 1141636.4 | 434262.2 | · | 445897.1 | · | |
| P / Tangible Book | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | 317201.6 | · | · | · | · | · | |
| P / Cash Flow | -0.4 | -5.3 | -9781.2 | -23235.6 | -57896.4 | · | -318978.3 | -256780.7 | · | -611666.0 | · | |
| P / FCF | · | · | · | -23203.6 | -56052.9 | · | -317831.0 | -251997.7 | · | -572642.7 | · | |
| EV / EBITDA | · | · | · | -17607.8 | -61962.0 | · | -334958.7 | -267968.8 | · | -182445.8 | · | |
| EV / FCF | · | · | · | -23202.7 | -56051.4 | · | -317831.2 | -251997.5 | · | -572641.7 | · | |
| EV / Revenue | · | · | · | 156852.8 | 102107.2 | · | 416952.4 | 572426.6 | · | 2258106.7 | · | |
| Earnings Yield | -925.5% | -36496.8% | -39.3% | 0.00% | 0.00% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $4M | $5M | $4M | |
| SG&A Expense | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-7M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $87.0K | $140.0K | $190.0K | $61.0K | $22.0K | $72.0K | $70.0K | $112.0K | $141.0K | $149.0K | $188.0K | $227.0K | $230.0K | $-67.0K | $21.0K | $-25.0K | |
| Net Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-6M | $-8M | $3M | $-5M | $-8M | |
| EPS (Basic) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| EPS (Diluted) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| Shares (Basic) | 1,196,364 | 1,060,678 | · | 4,049,046 | 41,008 | 4,051 | · | 14,254 | 4,756 | 18,560 | · | 285,886 | 147,321 | 159,597 | · | 5,090,592 | |
| Shares (Diluted) | 1,196,364 | 1,060,678 | · | 4,049,046 | 41,008 | 4,051 | · | 14,254 | 4,756 | 18,560 | · | 285,886 | 147,321 | 159,597 | · | 5,090,592 | |
| EBITDA | $-6M | · | · | $-8M | $-6M | $-6M | · | $-5M | $-6M | $-7M | · | $-7M | $-8M | $-8M | · | $-8M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $15M | $22M | $21M | $9M | $2M | $9M | $8M | $8M | $10M | $17M | $19M | $21M | $25M | $23M | $22M | |
| Prepaid Expense | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $798.0K | $1M | $1M | $1M | $910.0K | $2M | $2M | $1M | |
| Other Current Assets | $462.0K | $851.0K | $853.0K | $77.0K | $82.0K | $120.0K | $1M | $624.0K | $715.0K | $691.0K | $689.0K | $649.0K | $764.0K | $2M | $744.0K | $658.0K | |
| Current Assets | $11M | $16M | $23M | $23M | $11M | $4M | $11M | $10M | $10M | $12M | $19M | $21M | $23M | $28M | $27M | $25M | |
| PP&E (Net) | $236.0K | $268.0K | $303.0K | $384.0K | $432.0K | $482.0K | $543.0K | $614.0K | $697.0K | $789.0K | $895.0K | $1M | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | |
| Accum. Depreciation | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $13M | · | |
| Total Assets | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Accounts Payable | $1M | $890.0K | $877.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $5M | $5M | $6M | $6M | $5M | $5M | $6M | $6M | $5M | $6M | $7M | $7M | $7M | $6M | $9M | $8M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $14.0K | $14.0K | $14.0K | · | · | · | · | · | · | |
| Total Liabilities | $8M | $8M | $10M | $10M | $9M | $10M | $11M | $11M | $10M | $12M | $13M | $12M | $13M | $12M | $16M | $16M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $3M | $4M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Common Stock | $114.0K | $114.0K | $114.0K | $110.0K | $99.0K | $84.0K | $84.0K | $82.0K | $69.0K | $66.0K | $61.0K | $56.0K | $49.0K | $49.0K | $48.0K | $47.0K | |
| Retained Earnings | $-288M | $-282M | $-275M | $-269M | $-260M | $-254M | $-248M | $-241M | $-236M | $-230M | $-223M | $-218M | $-211M | $-203M | $-206M | $-201M | |
| Stockholders' Equity | $6M | $12M | $17M | $17M | $7M | $-1M | $5M | $4M | $4M | $6M | $12M | $15M | $16M | $23M | $18M | $16M | |
| Liabilities + Equity | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Shares Outstanding | 1,418,952 | 1,203,753 | 997,830 | 13,808,966 | 3,224,156 | 1,458,504 | 4,051 | 17,050,536 | 4,080,665 | 673,430 | 11,958 | 14,465,703 | 7,543,440 | 7,239,471 | 6,466,294 | 5,090,644 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $32.0K | $35.0K | $81.0K | $49.0K | $49.0K | $61.0K | $71.0K | $84.0K | $91.0K | $106.0K | $116.0K | $123.0K | $150.0K | $178.0K | $161.0K | $222.0K | |
| Stock-based Comp | $58.0K | $57.0K | $2.0K | $77.0K | $-163.0K | $180.0K | $-72.0K | $149.0K | $273.0K | $719.0K | $358.0K | $455.0K | $465.0K | $915.0K | $357.0K | $359.0K | |
| Other Non-cash | · | · | · | · | · | $-408.0K | · | · | · | $-642.0K | · | · | · | $700.0K | · | · | |
| Operating Cash Flow | $-5M | $-8M | $-5M | $-7M | $-7M | $-7M | $-6M | $-5M | $-6M | $-7M | $-5M | $-6M | $-5M | $5M | $-6M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $4.0K | |
| Investing Cash Flow | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | $-4.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · | |
| Stock Issued | $726.0K | $872.0K | $32M | $-9M | $14M | $0 | · | $6M | · | · | $3M | $1M | $481.0K | $2M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $6M | · | · | · | · | · | $2M | · | · | |
| Financing Cash Flow | $726.0K | $871.0K | $6M | $18M | $14M | $0 | $7M | $5M | $4M | $-3.0K | $3M | $4M | $481.0K | $-2M | $6M | $-500.0K | |
| Net Change in Cash | $-5M | $-7M | $558.0K | $12M | $7M | $-7M | $961.0K | $-313.0K | $-2M | $-7M | $-2M | $-2M | $-4M | $3M | $59.0K | $-7M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -42.2% | · | · | -35.8% | -40.6% | -49.4% | · | -24.1% | -26.8% | -26.0% | · | -21.5% | -23.5% | 6.9% | · | -16.0% | |
| ROE | -101.2% | · | · | -69.2% | -112.9% | -276.8% | · | -53.3% | -56.8% | -46.6% | · | -41.6% | -40.5% | 31.9% | · | -66.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | · | · | 4.0 | 2.3 | 0.7 | · | 1.7 | 1.8 | 1.9 | · | 3.1 | 3.3 | 4.9 | · | 3.2 | |
| Quick Ratio | 1.9 | · | · | 3.8 | 1.9 | 0.4 | · | 1.3 | 1.5 | 1.6 | · | 2.8 | 3.0 | 4.4 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.26 | · | · | $1.26 | $2.02 | $-1.01 | · | $0.26 | $1.09 | $9.06 | · | $1.02 | $2.15 | $3.21 | · | $3.10 | |
| Cash Flow / Share | · | · | · | · | · | $-4.51 | · | · | · | $-9.69 | · | · | · | $0.65 | · | · | |
| Cash / Share | $6.90 | · | · | $1.53 | $2.92 | $1.47 | · | $0.45 | $1.98 | $15.22 | · | $1.32 | $2.78 | $3.50 | · | $4.35 | |
| EPS (TTM) | $-86.20 | $-1598.85 | · | $-31232.53 | $-31588.16 | $-32673.83 | · | $-4221.13 | $-3885.43 | $-2702.42 | · | $-59.69 | $-39.03 | $20.50 | · | $1.26 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $12M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $7M | |
| Net Income TTM | $-26M | $-27M | · | $-26M | $-24M | $-24M | · | $-24M | $-25M | $-27M | · | $-16M | $-17M | $18M | · | $6M | |
| Market Cap | $6M | · | · | $20M | $10M | $34M | · | $2.27B | $924M | $2.34B | · | $155.43B | $358.60B | $479.68B | · | $503.88B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $503.87B | |
| P/E | -0.1 | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 | -0.1 | -1.3 | · | -180.0 | -1218.0 | 3232.2 | · | 78557.5 | |
| P/S | 2.0 | · | · | 6.4 | 3.2 | 10.9 | · | 729.3 | 296.7 | 750.5 | · | 49913.6 | 115156.4 | 154041.3 | · | 74330.2 | |
| P/B | 1.0 | · | · | 1.2 | 1.5 | -23.0 | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Tangible Book | 1.0 | 0.4 | · | 1.2 | 1.5 | · | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Cash Flow | · | · | · | · | · | -5.1 | · | · | · | -351.4 | · | · | · | 105055.7 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 74327.5 | |
| Earnings Yield | -1941.4% | -37443.8% | · | -2153967.6% | -1035677.4% | -140835.5% | · | -3169.0% | -1715.9% | -77.9% | · | -0.56% | -0.08% | 0.03% | · | 0.00% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | · | $3M | $12M |
| Margine Operativo % | · | · | · | -919.8% | -174.1% |
| Utile netto | $-26M | $-24M | $-17M | $8M | $-28M |
| EPS Diluito | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | · | 0.2 | 9.6 |
| Rapporto corrente | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 |
| Quick Ratio | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | $-21M | $-22M |
Proprietari istituzionali (13F) 11 filer · $287K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
11
Valore detenuto
$287K
Nuove posizioni
1
Posizioni chiuse
0
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 1 (-3 vs trimestre precedente) | 0 (-4 vs trimestre precedente) | 1 (-1 vs trimestre precedente) | 2 (+1 vs trimestre precedente) | -3K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $158.952 | 16.856 | 55,30% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $56.446 | 12.713 | 19,64% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $48.044 | 10.821 | 16,72% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $18.390 | 4.142 | 6,40% | Azioni |
| UBS Group AG | $3.242 | 730 | 1,13% | Azioni |
| OSAIC HOLDINGS, INC. | $1.596 | 360 | 0,56% | Azioni |
| SBI Securities Co., Ltd. | $484 | 109 | 0,17% | Azioni |
| BARCLAYS PLC | $138 | 31 | 0,05% | Azioni |
| GSA CAPITAL PARTNERS LLP | $96 | 21.539 | 0,03% | Azioni |
| CWM, LLC | $21 | 5 | 0,01% | Azioni |
| DANSKE BANK A/S | $4 | 1 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×6 depositi | 26 Novembre 2021 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata | 03 Agosto 2016 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 17 insider · 5 dirigenti · 1 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jane A Gross | SVP & Chief Scientific Officer | 29 Gennaio 2021 A | 109.583 | 0 | 0 | $0 |
| Randy Joe Maddux | SVP of Operations, CMO | 27 Luglio 2020 A | 75.000 | 0 | 0 | $0 |
| Michael Adelman | SVP, Commercial Operations | 18 Febbraio 2020 A | 70.426 | 0 | 0 | $0 |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | 18 Febbraio 2020 A | 80.527 | 0 | 0 | $0 |
| Scott C Stromatt | Chief Medical Officer and SVP | 01 Marzo 2019 M | 216.183 | 0 | 0 | $0 |
| Fuad El-Hibri | Direttore | 03 Dicembre 2021 J | 7.373 | 0 | 0 | $0 |
| Emergent BioSolutions Inc. | Proprietario del 10% | 01 Agosto 2016 J | 0 | 0 | 0 | $0 |
| Soyoung Kwon | · | 06 Agosto 2026 M | 638 | 0 | 0 | $0 |
| Dirk Huebner | · | 06 Agosto 2026 M | 482 | 0 | 0 | $0 |
| Barbara Lopez Kunz | · | 06 Agosto 2026 M | 400 | 0 | 0 | $0 |
| Jeffrey G. Lamothe | · | 06 Agosto 2026 M | 961 | 0 | 0 | $0 |
| Grady Grant III | · | 06 Agosto 2026 M | 1.150 | 1 | 0 | $20.134 |
| John Niederhuber | · | 06 Agosto 2026 M | 400 | 0 | 0 | $0 |
| Marvin L White | · | 06 Agosto 2026 M | 1.261 | 0 | 0 | $0 |
| Daphne Taylor | · | 06 Agosto 2026 M | 638 | 0 | 0 | $0 |
| Daniel Abdun-Nabi | · | 06 Agosto 2026 M | 400 | 0 | 0 | $0 |
| Zsolt Harsanyi | · | 06 Agosto 2026 M | 400 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12.713 SH | 19 Agosto 2026 | Giornaliero |
APVO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
Target mediano
$25.50
+1348,9%
2 28,6%
Acquisto forte
4 57,1%
Compra
1 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
2 analisti · 2026-09-30Target medio $25.50 +1348,9%
← Sotto tutti i target
Prezzo attuale $1.76
Basso$21.00
Media$25.50
Alto$30.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| APVO | $9M | -0.1 | · | · | -217.2% | · |
| MBIO | · | -2.5 | · | · | -30.9% | · |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | · |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| GOVX | $296.2K | · | -37.1% | -862.3% | -645.9% | · |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| REVB | · | · | · | · | · | · |
| DCOY | · | -0.0 | · | · | · | · |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| SBFM | · | · | · | · | · | · |
| BCAB | · | -0.6 | · | · | · | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 14, 2026